A 71-year-old man had had visual hallucinations and vivid dreams for two years after starting to take metoprolol. When metoprolol was replaced by atenolol the patient's symptoms disappeared within five days. Side-effects of beta-blockers on the central nervous system are relatively uncommon. The mechanisms underlying these side-effects are not fully understood. Lipophilic beta-blockers can cross the blood-brain barrier, whereas hydrophilic beta-blockers cannot. Doctors need to be alerted to the varying side-effects of specific beta-blockers.

Download full-text PDF

Source

Publication Analysis

Top Keywords

vivid dreams
8
[hallucinations vivid
4
dreams metoprolol]
4
metoprolol] 71-year-old
4
71-year-old man
4
man visual
4
visual hallucinations
4
hallucinations vivid
4
dreams years
4
years starting
4

Similar Publications

Effects of ketamine and propofol on muscarinic plateau potentials in rat neocortical pyramidal cells.

PLoS One

January 2025

Department of Molecular Medicine, Brain Signalling Laboratory, Institute of Basic Medical Sciences, Section for Physiology, University of Oslo, Oslo, Norway.

Propofol and ketamine are widely used general anaesthetics, but have different effects on consciousness: propofol gives a deeply unconscious state, with little or no dream reports, whereas vivid dreams are often reported after ketamine anaesthesia. Ketamine is an N-methyl-D-aspartate (NMDA) receptor antagonist, while propofol is a γ-aminobutyric-acid (GABAA) receptor positive allosteric modulator, but these mechanisms do not fully explain how these drugs alter consciousness. Most previous in vitro studies of cellular mechanisms of anaesthetics have used brain slices or neurons in a nearly "comatose" state, because no "arousing" neuromodulators were added.

View Article and Find Full Text PDF

A Cognitive Approach to Maladaptive Daydreaming.

Indian J Psychol Med

November 2024

Dept. of Clinical Psychology, Manipal College of Health Professions, Manipal Academy of Higher Education, Manipal, Udupi, Karnataka, India.

Background Of The Study: Maladaptive daydreaming (MDD) is a mental activity that develops from unconscious material but differs from normal daydreaming in terms of experience, content, quantity, control, distress, and interference with everyday living. Dreaming often involves fantasizing about an idealized self, which includes motifs of companionship, romance, and compensatory scripts like power, escape, and rescue. The MDD is understood as a form of unusual imagination that is vivid and addictive but impedes academic and occupational responsibilities.

View Article and Find Full Text PDF

Background: Fibromyalgia is characterized by the presence of chronic widespread pain that may impair patient's quality of life. Currently, the use of naltrexone as a therapeutic agent for fibromyalgia is not supported by enough evidence, especially from randomized controlled trials (RCTs). This study aims to analyze the efficacy and safety of low-dose naltrexone (LDN) for the management of fibromyalgia.

View Article and Find Full Text PDF
Article Synopsis
  • The BIOMAG-I study evaluated the first-in-human resorbable magnesium scaffold (DREAMS 3G) and showed positive outcomes for clinical results and late lumen loss after 12 months.
  • The current substudy looked into vascular healing parameters using optical coherence tomography (OCT) and intravascular ultrasound (IVUS), focusing on aspects like strut visibility and neointimal growth.
  • Results from 56 patients indicated that almost all scaffold struts became invisible by 12 months, with a favorable vascular healing response, including a significant decrease in protruding neointimal tissue.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!